Need professional-grade analysis? Visit stockanalysis.com
$4.77B
N/A
N/A
N/A
Sumitomo Dainippon Pharma Co. Ltd (DNPUF) trades on United States in USD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at $14.48, up 30.29% from the previous close.
Over the past year, DNPUF has traded between a low of $11.11 and a high of $14.48. The stock has gained 6.2% over this period. It is currently 30.3% above its 52-week low.
Sumitomo Dainippon Pharma Co. Ltd has a market capitalization of $4.77B.
Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson's disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.
Side-by-side comparison against top Healthcare peers.